
<div id="jpedal" style="overflow: hidden; position: relative; width: 880px; height: 1182px;">
<style type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position:absolute;
	white-space:nowrap;
	overflow:visible;
}
</style>
<style type="text/css" >

#t1_4{left:66px;top:558px;word-spacing:-0.6px;}
#t2_4{left:206px;top:558px;}
#t3_4{left:215px;top:558px;word-spacing:-0.7px;}
#t4_4{left:66px;top:576px;word-spacing:3.6px;}
#t5_4{left:66px;top:593px;word-spacing:2.5px;}
#t6_4{left:66px;top:611px;word-spacing:11.9px;}
#t7_4{left:66px;top:628px;word-spacing:23.9px;}
#t8_4{left:116px;top:628px;word-spacing:23.7px;}
#t9_4{left:66px;top:646px;word-spacing:4.7px;}
#ta_4{left:66px;top:663px;word-spacing:2.9px;}
#tb_4{left:66px;top:681px;word-spacing:-2.3px;}
#tc_4{left:66px;top:698px;word-spacing:2px;}
#td_4{left:172px;top:698px;}
#te_4{left:195px;top:698px;word-spacing:2px;}
#tf_4{left:66px;top:716px;word-spacing:-0.7px;}
#tg_4{left:66px;top:733px;word-spacing:26.3px;}
#th_4{left:66px;top:751px;word-spacing:6.7px;}
#ti_4{left:152px;top:751px;word-spacing:6.8px;}
#tj_4{left:218px;top:751px;}
#tk_4{left:225px;top:751px;}
#tl_4{left:244px;top:751px;word-spacing:6.8px;}
#tm_4{left:366px;top:751px;}
#tn_4{left:375px;top:751px;word-spacing:6.7px;}
#to_4{left:66px;top:769px;}
#tp_4{left:104px;top:769px;}
#tq_4{left:112px;top:769px;word-spacing:15.9px;}
#tr_4{left:66px;top:786px;word-spacing:5.4px;}
#ts_4{left:66px;top:804px;word-spacing:1.8px;}
#tt_4{left:66px;top:855px;word-spacing:-0.9px;}
#tu_4{left:66px;top:879px;word-spacing:-0.4px;}
#tv_4{left:66px;top:896px;word-spacing:8.2px;}
#tw_4{left:399px;top:896px;}
#tx_4{left:407px;top:896px;}
#ty_4{left:66px;top:914px;word-spacing:7.4px;}
#tz_4{left:338px;top:914px;word-spacing:7.3px;}
#t10_4{left:377px;top:914px;word-spacing:7.4px;}
#t11_4{left:66px;top:931px;word-spacing:1.4px;}
#t12_4{left:66px;top:949px;word-spacing:9.1px;}
#t13_4{left:142px;top:949px;}
#t14_4{left:150px;top:949px;word-spacing:9.3px;}
#t15_4{left:66px;top:966px;word-spacing:8.4px;}
#t16_4{left:66px;top:984px;word-spacing:4.5px;}
#t17_4{left:66px;top:1001px;}
#t18_4{left:77px;top:1001px;word-spacing:-4.3px;}
#t19_4{left:66px;top:1019px;word-spacing:2.6px;}
#t1a_4{left:66px;top:1036px;word-spacing:0.1px;}
#t1b_4{left:90px;top:1054px;word-spacing:0.9px;}
#t1c_4{left:66px;top:1071px;word-spacing:-2px;}
#t1d_4{left:66px;top:1089px;word-spacing:19px;}
#t1e_4{left:333px;top:1089px;}
#t1f_4{left:342px;top:1089px;word-spacing:18.7px;}
#t1g_4{left:66px;top:1106px;word-spacing:19.6px;}
#t1h_4{left:362px;top:1106px;letter-spacing:-3.1px;}
#t1i_4{left:369px;top:1106px;}
#t1j_4{left:420px;top:1106px;letter-spacing:-2.7px;}
#t1k_4{left:454px;top:558px;word-spacing:19.5px;}
#t1l_4{left:454px;top:576px;word-spacing:7.4px;}
#t1m_4{left:529px;top:576px;}
#t1n_4{left:538px;top:576px;word-spacing:7.5px;}
#t1o_4{left:454px;top:593px;word-spacing:5.9px;}
#t1p_4{left:454px;top:611px;word-spacing:10.7px;}
#t1q_4{left:633px;top:611px;word-spacing:10.7px;}
#t1r_4{left:454px;top:628px;word-spacing:24.4px;}
#t1s_4{left:454px;top:646px;word-spacing:1.8px;}
#t1t_4{left:582px;top:646px;word-spacing:2.1px;}
#t1u_4{left:615px;top:646px;}
#t1v_4{left:454px;top:669px;word-spacing:2.3px;}
#t1w_4{left:735px;top:669px;word-spacing:2.5px;}
#t1x_4{left:454px;top:686px;word-spacing:5.9px;}
#t1y_4{left:762px;top:693px;}
#t1z_4{left:768px;top:686px;word-spacing:5.8px;}
#t20_4{left:454px;top:704px;word-spacing:5.3px;}
#t21_4{left:792px;top:704px;}
#t22_4{left:801px;top:704px;}
#t23_4{left:454px;top:721px;}
#t24_4{left:537px;top:721px;}
#t25_4{left:545px;top:721px;word-spacing:15.9px;}
#t26_4{left:454px;top:739px;}
#t27_4{left:473px;top:739px;}
#t28_4{left:482px;top:739px;word-spacing:12.6px;}
#t29_4{left:454px;top:756px;word-spacing:2.2px;}
#t2a_4{left:454px;top:774px;word-spacing:-1.1px;}
#t2b_4{left:454px;top:791px;word-spacing:7px;}
#t2c_4{left:454px;top:809px;word-spacing:11.2px;}
#t2d_4{left:454px;top:826px;word-spacing:14.1px;}
#t2e_4{left:454px;top:844px;word-spacing:1.8px;}
#t2f_4{left:478px;top:861px;word-spacing:21.7px;}
#t2g_4{left:454px;top:879px;word-spacing:18.6px;}
#t2h_4{left:454px;top:896px;word-spacing:-0.1px;}
#t2i_4{left:454px;top:914px;word-spacing:28.4px;}
#t2j_4{left:454px;top:931px;word-spacing:7.2px;}
#t2k_4{left:454px;top:949px;word-spacing:8.6px;}
#t2l_4{left:454px;top:966px;word-spacing:8.8px;}
#t2m_4{left:454px;top:984px;word-spacing:0.8px;}
#t2n_4{left:454px;top:1001px;word-spacing:6.7px;}
#t2o_4{left:454px;top:1019px;word-spacing:13.6px;}
#t2p_4{left:454px;top:1036px;word-spacing:3.6px;}
#t2q_4{left:454px;top:1054px;word-spacing:16.5px;}
#t2r_4{left:688px;top:1054px;word-spacing:16.3px;}
#t2s_4{left:725px;top:1054px;word-spacing:16.5px;}
#t2t_4{left:454px;top:1071px;word-spacing:12.4px;}
#t2u_4{left:454px;top:1089px;word-spacing:7.5px;}
#t2v_4{left:454px;top:1106px;word-spacing:1.7px;}
#t2w_4{left:537px;top:1106px;}
#t2x_4{left:556px;top:1106px;}
#t2y_4{left:563px;top:1106px;}
#t2z_4{left:582px;top:1106px;}
#t30_4{left:71px;top:100px;word-spacing:2.3px;}
#t31_4{left:72px;top:136px;word-spacing:1.2px;}
#t32_4{left:72px;top:158px;word-spacing:1.4px;}
#t33_4{left:234px;top:158px;word-spacing:1.3px;}
#t34_4{left:538px;top:158px;word-spacing:1.1px;}
#t35_4{left:72px;top:181px;word-spacing:1.1px;}
#t36_4{left:194px;top:181px;word-spacing:1.3px;}
#t37_4{left:461px;top:181px;word-spacing:0.8px;}
#t38_4{left:461px;top:195px;word-spacing:1.2px;}
#t39_4{left:72px;top:209px;letter-spacing:-0.1px;}
#t3a_4{left:194px;top:209px;}
#t3b_4{left:194px;top:222px;word-spacing:1.2px;}
#t3c_4{left:194px;top:236px;word-spacing:1.3px;}
#t3d_4{left:461px;top:209px;word-spacing:1.2px;}
#t3e_4{left:461px;top:222px;word-spacing:1.2px;}
#t3f_4{left:461px;top:236px;word-spacing:1.3px;}
#t3g_4{left:473px;top:250px;word-spacing:1.3px;}
#t3h_4{left:461px;top:263px;word-spacing:-1.8px;}
#t3i_4{left:473px;top:277px;word-spacing:1.2px;}
#t3j_4{left:72px;top:291px;word-spacing:1.4px;}
#t3k_4{left:194px;top:291px;word-spacing:1.3px;}
#t3l_4{left:461px;top:291px;word-spacing:-2.4px;}
#t3m_4{left:473px;top:304px;word-spacing:1.3px;}
#t3n_4{left:461px;top:318px;word-spacing:1.3px;}
#t3o_4{left:721px;top:318px;}
#t3p_4{left:727px;top:318px;word-spacing:1.4px;}
#t3q_4{left:473px;top:332px;}
#t3r_4{left:72px;top:346px;word-spacing:1.1px;}
#t3s_4{left:194px;top:346px;word-spacing:1.4px;}
#t3t_4{left:194px;top:359px;word-spacing:1.4px;}
#t3u_4{left:194px;top:373px;}
#t3v_4{left:194px;top:387px;word-spacing:1.1px;}
#t3w_4{left:194px;top:400px;}
#t3x_4{left:461px;top:346px;word-spacing:1.1px;}
#t3y_4{left:596px;top:346px;}
#t3z_4{left:603px;top:346px;word-spacing:1.3px;}
#t40_4{left:461px;top:359px;word-spacing:1.1px;}
#t41_4{left:473px;top:373px;}
#t42_4{left:461px;top:387px;word-spacing:1.2px;}
#t43_4{left:72px;top:414px;word-spacing:1.3px;}
#t44_4{left:194px;top:414px;word-spacing:1.2px;}
#t45_4{left:206px;top:428px;word-spacing:1.3px;}
#t46_4{left:206px;top:441px;word-spacing:1.3px;}
#t47_4{left:461px;top:414px;word-spacing:1.2px;}
#t48_4{left:461px;top:428px;word-spacing:1.2px;}
#t49_4{left:72px;top:455px;}
#t4a_4{left:194px;top:455px;word-spacing:1.3px;}
#t4b_4{left:363px;top:455px;}
#t4c_4{left:370px;top:455px;}
#t4d_4{left:206px;top:469px;word-spacing:1.3px;}
#t4e_4{left:461px;top:455px;word-spacing:1.2px;}
#t4f_4{left:473px;top:469px;word-spacing:1.2px;}
#t4g_4{left:473px;top:482px;word-spacing:1.3px;}
#t4h_4{left:72px;top:496px;}
#t4i_4{left:95px;top:496px;}
#t4j_4{left:114px;top:496px;}
#t4k_4{left:124px;top:496px;word-spacing:0.1px;}
#t4l_4{left:256px;top:496px;}
#t4m_4{left:266px;top:496px;word-spacing:-0.3px;}
#t4n_4{left:372px;top:496px;}
#t4o_4{left:377px;top:496px;}
#t4p_4{left:491px;top:496px;}
#t4q_4{left:501px;top:496px;word-spacing:0.5px;}
#t4r_4{left:648px;top:496px;}
#t4s_4{left:658px;top:496px;}
#t4t_4{left:767px;top:496px;}
#t4u_4{left:776px;top:496px;}
#t4v_4{left:72px;top:507px;word-spacing:1px;}
#t4w_4{left:204px;top:507px;}
#t4x_4{left:214px;top:507px;word-spacing:1px;}
#t4y_4{left:72px;top:524px;letter-spacing:-0.3px;word-spacing:0.8px;}
#t4z_4{left:173px;top:524px;}
#t50_4{left:178px;top:524px;letter-spacing:-0.3px;word-spacing:1.1px;}
#t51_4{left:66px;top:1142px;}
#t52_4{left:684px;top:1142px;word-spacing:1.4px;}
#t53_4{left:66px;top:41px;letter-spacing:0.1px;word-spacing:1.8px;}

.s21_4{
	FONT-SIZE: 60.9px;
	FONT-FAMILY: GANPFO-AdvOT156ec7734;
	color: rgb(0,0,0);
}

.s11_4{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: GANPEE-AdvOTa018106b-B4;
	color: rgb(0,0,0);
}

.s9_4{
	FONT-SIZE: 38.6px;
	FONT-FAMILY: GANPEF-AdvOTc856fc334;
	color: rgb(0,0,0);
}

.s16_4{
	FONT-SIZE: 36.5px;
	FONT-FAMILY: GAOACO-AdvP4C4E744;
	color: rgb(0,0,0);
}

.s3_4{
	FONT-SIZE: 57.8px;
	FONT-FAMILY: GANPEF-AdvOTc856fc334;
	color: rgb(13,128,172);
}

.s8_4{
	FONT-SIZE: 57.8px;
	FONT-FAMILY: GANPEE-AdvOTa018106b-B4;
	color: rgb(0,0,0);
}

.s6_4{
	FONT-SIZE: 57.8px;
	FONT-FAMILY: GAOACO-AdvP4C4E744;
	color: rgb(0,0,0);
}

.s1_4{
	FONT-SIZE: 57.8px;
	FONT-FAMILY: GANPEF-AdvOTc856fc334;
	color: rgb(0,0,0);
}

.s2_4{
	FONT-SIZE: 57.8px;
	FONT-FAMILY: GANPEH-AdvOTc856fc33-fb4;
	color: rgb(0,0,0);
}

.s4_4{
	FONT-SIZE: 57.8px;
	FONT-FAMILY: GANPEG-AdvOTc856fc33-204;
	color: rgb(13,128,172);
}

.s7_4{
	FONT-SIZE: 57.8px;
	FONT-FAMILY: GANPEG-AdvOTc856fc33-204;
	color: rgb(0,0,0);
}

.s18_4{
	FONT-SIZE: 36.5px;
	FONT-FAMILY: GAOABN-AdvOTbbf9ad4d-I-204;
	color: rgb(0,0,0);
}

.s19_4{
	FONT-SIZE: 42.6px;
	FONT-FAMILY: GANPEE-AdvOTa018106b-B4;
	color: rgb(205,21,29);
}

.s15_4{
	FONT-SIZE: 36.5px;
	FONT-FAMILY: GANPFO-AdvOT156ec7734;
	color: rgb(0,0,0);
}

.s14_4{
	FONT-SIZE: 36.5px;
	FONT-FAMILY: GAOABM-AdvOTbbf9ad4d-I4;
	color: rgb(0,0,0);
}

.s17_4{
	FONT-SIZE: 36.5px;
	FONT-FAMILY: GAOABL-AdvOT156ec773-204;
	color: rgb(0,0,0);
}

.s20_4{
	FONT-SIZE: 42.6px;
	FONT-FAMILY: GANPFO-AdvOT156ec7734;
	color: rgb(0,0,0);
}

.s12_4{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: GANPFO-AdvOT156ec7734;
	color: rgb(109,110,113);
}

.s13_4{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: GAOACP-AdvOT156ec773-fb4;
	color: rgb(109,110,113);
}

.s10_4{
	FONT-SIZE: 60.9px;
	FONT-FAMILY: GANPEE-AdvOTa018106b-B4;
	color: rgb(255,255,255);
}

.s5_4{
	FONT-SIZE: 60.9px;
	FONT-FAMILY: GANPFM-AdvOT2b189473-B4;
	color: rgb(205,21,29);
}

.v1_4{
	-webkit-transform: scale(0.281, 0.25);
	-ms-transform: scale(0.281, 0.25);
	-moz-transform: scale(0.281, 0.25);
	-o-transform: scale(0.281, 0.25);
}

#form4_1{	border-style:none;	z-index:2;	position: absolute;	left:171px;	top:700px;	width:25px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_2{	border-style:none;	z-index:2;	position: absolute;	left:581px;	top:648px;	width:35px;	height:15px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_3{	border-style:none;	z-index:2;	position: absolute;	left:688px;	top:1056px;	width:38px;	height:15px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_4{	border-style:none;	z-index:2;	position: absolute;	left:338px;	top:915px;	width:40px;	height:15px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_5{	border-style:none;	z-index:2;	position: absolute;	left:536px;	top:1108px;	width:46px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_6{	border-style:none;	z-index:2;	position: absolute;	left:64px;	top:630px;	width:52px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_7{	border-style:none;	z-index:2;	position: absolute;	left:151px;	top:752px;	width:93px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_8{	border-style:none;	z-index:2;	position: absolute;	left:452px;	top:613px;	width:182px;	height:15px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}

</style>
<style id="fonts4" type="text/css" >

@font-face {
	font-family: GAOACO-AdvP4C4E744;
	src: url("4/fonts/GAOACO-AdvP4C4E74.woff") format("woff");
}

@font-face {
	font-family: GANPFM-AdvOT2b189473-B4;
	src: url("4/fonts/GANPFM-AdvOT2b189473-B.woff") format("woff");
}

@font-face {
	font-family: GAOABN-AdvOTbbf9ad4d-I-204;
	src: url("4/fonts/GAOABN-AdvOTbbf9ad4d-I-20.woff") format("woff");
}

@font-face {
	font-family: GANPEE-AdvOTa018106b-B4;
	src: url("4/fonts/GANPEE-AdvOTa018106b-B.woff") format("woff");
}

@font-face {
	font-family: GAOACP-AdvOT156ec773-fb4;
	src: url("4/fonts/GAOACP-AdvOT156ec773-fb.woff") format("woff");
}

@font-face {
	font-family: GANPEH-AdvOTc856fc33-fb4;
	src: url("4/fonts/GANPEH-AdvOTc856fc33-fb.woff") format("woff");
}

@font-face {
	font-family: GANPFO-AdvOT156ec7734;
	src: url("4/fonts/GANPFO-AdvOT156ec773.woff") format("woff");
}

@font-face {
	font-family: GAOABL-AdvOT156ec773-204;
	src: url("4/fonts/GAOABL-AdvOT156ec773-20.woff") format("woff");
}

@font-face {
	font-family: GAOABM-AdvOTbbf9ad4d-I4;
	src: url("4/fonts/GAOABM-AdvOTbbf9ad4d-I.woff") format("woff");
}

@font-face {
	font-family: GANPEG-AdvOTc856fc33-204;
	src: url("4/fonts/GANPEG-AdvOTc856fc33-20.woff") format("woff");
}

@font-face {
	font-family: GANPEF-AdvOTc856fc334;
	src: url("4/fonts/GANPEF-AdvOTc856fc33.woff") format("woff");
}

</style>
<div id="t1_4" class="t s1_4">medical TRT is given at</div>
<div id="t2_4" class="t s2_4">f</div>
<div id="t3_4" class="t s1_4">xed replacement doses and may not</div>
<div id="t4_4" class="t s1_4">be a good model to describe pharmacodynamics in the AAS</div>
<div id="t5_4" class="t s1_4">user. Although some evidence exists describing the recovery</div>
<div id="t6_4" class="t s1_4">period after exogenous T used as a hormone replacement</div>
<div id="t7_4" class="t s3_4">(52, 53)</div>
<div id="t8_4" class="t s1_4">, it is likely that a more complex and global</div>
<div id="t9_4" class="t s1_4">endocrine disruption exists for the AAS user because of the</div>
<div id="ta_4" class="t s1_4">stacking and cycling of multiple high-dose synthetic andro-</div>
<div id="tb_4" class="t s1_4">gens and other ancillary drugs, culminating in a unique phar-</div>
<div id="tc_4" class="t s1_4">macologic milieu</div>
<div id="td_4" class="t s3_4">(48)</div>
<div id="te_4" class="t s1_4">. Beyond the systemic consequences of</div>
<div id="tf_4" class="t s1_4">hypogonadotropic hypogonadism, nonhuman animal studies</div>
<div id="tg_4" class="t s1_4">suggest direct testicular toxicity results from synthetic</div>
<div id="th_4" class="t s1_4">androgen use</div>
<div id="ti_4" class="t s3_4">(29, 50, 54</div>
<div id="tj_4" class="t s4_4">–</div>
<div id="tk_4" class="t s3_4">58)</div>
<div id="tl_4" class="t s1_4">. However, the signi</div>
<div id="tm_4" class="t s2_4">f</div>
<div id="tn_4" class="t s1_4">cance of</div>
<div id="to_4" class="t s1_4">these</div>
<div id="tp_4" class="t s2_4">f</div>
<div id="tq_4" class="t s1_4">ndings is not well established, and the extent to</div>
<div id="tr_4" class="t s1_4">which heavy AAS use might contribute to primary gonadal</div>
<div id="ts_4" class="t s1_4">failure remains unclear and warrants further study.</div>
<div id="tt_4" class="t s5_4">Adverse Effects and Treatment Recommendations</div>
<div id="tu_4" class="t s1_4">AAS users commonly report side effects that they consider to</div>
<div id="tv_4" class="t s1_4">be esthetically unpleasing, such as testicular atrophy,</div>
<div id="tw_4" class="t s2_4">ﬂ</div>
<div id="tx_4" class="t s1_4">uid</div>
<div id="ty_4" class="t s1_4">retention, acne, gynecomastia, and alopecia</div>
<div id="tz_4" class="t s3_4">(9, 16)</div>
<div id="t10_4" class="t s1_4">. Sexual</div>
<div id="t11_4" class="t s1_4">dysfunction was reported by 25% of users, and symptoms of</div>
<div id="t12_4" class="t s1_4">androgen de</div>
<div id="t13_4" class="t s2_4">f</div>
<div id="t14_4" class="t s1_4">ciency, including fatigue and depression, are</div>
<div id="t15_4" class="t s1_4">common complaints, especially during a post-cycle period.</div>
<div id="t16_4" class="t s1_4">Polycythemia also is a common adverse event, occurring in</div>
<div id="t17_4" class="t s6_4">±</div>
<div id="t18_4" class="t s1_4">40% of patients. Long-term AAS users may have serious un-</div>
<div id="t19_4" class="t s1_4">derlying hepatic, renal, and cardiovascular disease, with hy-</div>
<div id="t1a_4" class="t s1_4">pertension and dyslipidemia common among chronic users.</div>
<div id="t1b_4" class="t s1_4">ASIH arises from the combination of hyperandrogenism,</div>
<div id="t1c_4" class="t s1_4">resulting from the supraphysiologic supplementation of AAS,</div>
<div id="t1d_4" class="t s1_4">and subsequent hypogonadism. This T de</div>
<div id="t1e_4" class="t s2_4">f</div>
<div id="t1f_4" class="t s1_4">ciency occurs</div>
<div id="t1g_4" class="t s1_4">because typical AAS users alternate between</div>
<div id="t1h_4" class="t s7_4">‘‘</div>
<div id="t1i_4" class="t s1_4">on-cycle</div>
<div id="t1j_4" class="t s7_4">’’</div>
<div id="t1k_4" class="t s1_4">supraphysiologic plasma androgen levels and periods of</div>
<div id="t1l_4" class="t s1_4">androgen de</div>
<div id="t1m_4" class="t s2_4">f</div>
<div id="t1n_4" class="t s1_4">ciency where ancillary drugs such as SERMs,</div>
<div id="t1o_4" class="t s1_4">AIs, and hCG are used in attempts to recover the HPG axis</div>
<div id="t1p_4" class="t s3_4">(7, 9, 17, 19, 25, 32, 48, 59)</div>
<div id="t1q_4" class="t s1_4">. Via suppression of estrogen</div>
<div id="t1r_4" class="t s1_4">and thus its negative feedback, the hypothalamus can</div>
<div id="t1s_4" class="t s1_4">restart the HPG axis (</div>
<div id="t1t_4" class="t s3_4">Fig. 1</div>
<div id="t1u_4" class="t s1_4">).</div>
<div id="t1v_4" class="t s8_4">Diagnostic and treatment recommendations.</div>
<div id="t1w_4" class="t s1_4">Initial testing</div>
<div id="t1x_4" class="t s1_4">typically consists of a hormonal panel (LH, FSH, E</div>
<div id="t1y_4" class="t v1_4 s9_4">2</div>
<div id="t1z_4" class="t s1_4">, T, free</div>
<div id="t20_4" class="t s1_4">T, SHBG, and PRL), complete blood cell count, lipid pro</div>
<div id="t21_4" class="t s2_4">f</div>
<div id="t22_4" class="t s1_4">le,</div>
<div id="t23_4" class="t s1_4">prostate-speci</div>
<div id="t24_4" class="t s2_4">f</div>
<div id="t25_4" class="t s1_4">c antigen, and a comprehensive metabolic</div>
<div id="t26_4" class="t s1_4">pro</div>
<div id="t27_4" class="t s2_4">f</div>
<div id="t28_4" class="t s1_4">le. Common post-cycle complaints include depressive</div>
<div id="t29_4" class="t s1_4">mood alterations, fatigue, lethargy, insomnia, and decreased</div>
<div id="t2a_4" class="t s1_4">libido, and any such symptoms should be addressed. Physical</div>
<div id="t2b_4" class="t s1_4">examination should include height, weight, blood pressure,</div>
<div id="t2c_4" class="t s1_4">and body mass index, and common signs consistent with</div>
<div id="t2d_4" class="t s1_4">AAS use, such as acne, gynecomastia, testicular atrophy,</div>
<div id="t2e_4" class="t s1_4">skin striations, and alopecia should be noted if present.</div>
<div id="t2f_4" class="t s1_4">For AAS users seeking treatment and assistance in</div>
<div id="t2g_4" class="t s1_4">permanently discontinuing AAS, certain steps should be</div>
<div id="t2h_4" class="t s1_4">taken. Following establishment of a nonjudgmental, healthy,</div>
<div id="t2i_4" class="t s1_4">and trusting physician-patient relationship, the patient</div>
<div id="t2j_4" class="t s1_4">should be counseled to discontinue all AAS as well as any</div>
<div id="t2k_4" class="t s1_4">self-administered ancillary drugs and supplements. For the</div>
<div id="t2l_4" class="t s1_4">severely symptomatic patients, a 4-week tapered course of</div>
<div id="t2m_4" class="t s1_4">transdermal or injectable TRT may provide immediate symp-</div>
<div id="t2n_4" class="t s1_4">tom improvement. Simultaneous administration of a SERM</div>
<div id="t2o_4" class="t s1_4">(such as clomiphene citrate, 25 mg every other day) will</div>
<div id="t2p_4" class="t s1_4">interact at the hypothalamus causing stimulation of LH and</div>
<div id="t2q_4" class="t s1_4">ultimately increase intratesticular T (</div>
<div id="t2r_4" class="t s3_4">Fig. 1</div>
<div id="t2s_4" class="t s1_4">). For patients</div>
<div id="t2t_4" class="t s1_4">with ASIH-induced gynecomastia, 20 mg tamoxifen daily</div>
<div id="t2u_4" class="t s1_4">will block the breast estrogen receptors and stimulate HPG</div>
<div id="t2v_4" class="t s1_4">axis recovery</div>
<div id="t2w_4" class="t s3_4">(60</div>
<div id="t2x_4" class="t s4_4">–</div>
<div id="t2y_4" class="t s3_4">65)</div>
<div id="t2z_4" class="t s1_4">.</div>
<div id="t30_4" class="t s10_4">TABLE 1</div>
<div id="t31_4" class="t s11_4">Commonly reported user-reported side effects and concerns, user strategies for management, and physician recommendations.</div>
<div id="t32_4" class="t s11_4">Side effect</div>
<div id="t33_4" class="t s11_4">User strategies for management</div>
<div id="t34_4" class="t s11_4">What should physicians recommend?</div>
<div id="t35_4" class="t s12_4">Low endogenous T</div>
<div id="t36_4" class="t s12_4">SERMs to restart axis</div>
<div id="t37_4" class="t s12_4">Discontinue AAS</div>
<div id="t38_4" class="t s12_4">Start recovery protocol with TRT, SERMs, or hCG</div>
<div id="t39_4" class="t s12_4">Gynecomastia</div>
<div id="t3a_4" class="t s12_4">Tamoxifen</div>
<div id="t3b_4" class="t s12_4">Aromatase inhibitors</div>
<div id="t3c_4" class="t s12_4">Cabergoline and bromocriptine for galactorrhea</div>
<div id="t3d_4" class="t s12_4">Chronic gynecomastia likely unresponsive to medical management</div>
<div id="t3e_4" class="t s12_4">Surgical management is best option for chronic gynecomastia</div>
<div id="t3f_4" class="t s12_4">Acute gynecomastia may be treated with tamoxifen per SERM</div>
<div id="t3g_4" class="t s12_4">recovery protocol</div>
<div id="t3h_4" class="t s12_4">Avoid hCG use if possible. Use of aromatase inhibitors is discouraged</div>
<div id="t3i_4" class="t s12_4">because of possible sexual side effects</div>
<div id="t3j_4" class="t s12_4">Testicular atrophy</div>
<div id="t3k_4" class="t s12_4">hCG injections</div>
<div id="t3l_4" class="t s12_4">Testicular atrophy will resolve discontinuation of AAS and recovery of</div>
<div id="t3m_4" class="t s12_4">HPG axis function</div>
<div id="t3n_4" class="t s12_4">hCG should be reserved for cases unresponsive to</div>
<div id="t3o_4" class="t s13_4">f</div>
<div id="t3p_4" class="t s12_4">rst line SERM</div>
<div id="t3q_4" class="t s12_4">treatment</div>
<div id="t3r_4" class="t s12_4">Sexual dysfunction</div>
<div id="t3s_4" class="t s12_4">PDE5 inhibitors</div>
<div id="t3t_4" class="t s12_4">Herbal aphrodisiacs</div>
<div id="t3u_4" class="t s12_4">Cabergoline</div>
<div id="t3v_4" class="t s12_4">Mesterolone for added androgenic effects</div>
<div id="t3w_4" class="t s12_4">Dapoxetine</div>
<div id="t3x_4" class="t s12_4">PDE5 inhibitors should be</div>
<div id="t3y_4" class="t s13_4">f</div>
<div id="t3z_4" class="t s12_4">rst-line treatment</div>
<div id="t40_4" class="t s12_4">Herbal aphrodisiacs should be discouraged owing to contamination</div>
<div id="t41_4" class="t s12_4">concerns</div>
<div id="t42_4" class="t s12_4">Dapoxetine not yet approved for sexual dysfunction</div>
<div id="t43_4" class="t s12_4">Hepatic dysfunction</div>
<div id="t44_4" class="t s12_4">Users of oral AAS concerned with hepatic</div>
<div id="t45_4" class="t s12_4">function may take herbal supplements such</div>
<div id="t46_4" class="t s12_4">as milk thistle extract for liver protection</div>
<div id="t47_4" class="t s12_4">Encourage discontinuation of oral AAS and herbal supplementation</div>
<div id="t48_4" class="t s12_4">Perform complete metabolic panel to assess liver function</div>
<div id="t49_4" class="t s12_4">Alopecia</div>
<div id="t4a_4" class="t s12_4">Users often prophylactically take</div>
<div id="t4b_4" class="t s13_4">f</div>
<div id="t4c_4" class="t s12_4">nasteride</div>
<div id="t4d_4" class="t s12_4">to prevent hair loss</div>
<div id="t4e_4" class="t s12_4">Although AAS use may worsen existing alopecia, 5-alpha-reductase</div>
<div id="t4f_4" class="t s12_4">inhibitor use should be discouraged because it may worsen</div>
<div id="t4g_4" class="t s12_4">symptoms of ASIH</div>
<div id="t4h_4" class="t s14_4">Note:</div>
<div id="t4i_4" class="t s15_4">AAS</div>
<div id="t4j_4" class="t s16_4">¼</div>
<div id="t4k_4" class="t s15_4">anabolic-androgenic steroid; ASIH</div>
<div id="t4l_4" class="t s16_4">¼</div>
<div id="t4m_4" class="t s15_4">anabolic-androgenic steroid</div>
<div id="t4n_4" class="t s17_4">–</div>
<div id="t4o_4" class="t s15_4">induced hypogonadism; HPG</div>
<div id="t4p_4" class="t s16_4">¼</div>
<div id="t4q_4" class="t s15_4">hypothalamic-pituitary-gonadal; PDE5</div>
<div id="t4r_4" class="t s16_4">¼</div>
<div id="t4s_4" class="t s15_4">phosphodiesterase-5; SERM</div>
<div id="t4t_4" class="t s16_4">¼</div>
<div id="t4u_4" class="t s15_4">selective</div>
<div id="t4v_4" class="t s15_4">estrogen receptor modulator; TRT</div>
<div id="t4w_4" class="t s16_4">¼</div>
<div id="t4x_4" class="t s15_4">testosterone replacement therapy.</div>
<div id="t4y_4" class="t s14_4">Rahnema. Anabolic steroid</div>
<div id="t4z_4" class="t s18_4">–</div>
<div id="t50_4" class="t s14_4">induced hypogonadism. Fertil Steril 2014.</div>
<div id="t51_4" class="t s19_4">1274</div>
<div id="t52_4" class="t s20_4">VOL. 101 NO. 5 / MAY 2014</div>
<div id="t53_4" class="t s21_4">ORIGINAL ARTICLE: ANDROLOGY</div>

<form>
<input type="button"  tabindex="2"  id="form4_1" name="50 0 R"  pdfFieldName="50 0 R" onclick="window.location.href='8.html';" style="cursor:pointer;"  title="Page 8" />
<input type="button"  tabindex="6"  id="form4_2" name="54 0 R"  pdfFieldName="54 0 R" onclick="window.location.href='3.html';" style="cursor:pointer;"  title="Page 3" />
<input type="button"  tabindex="7"  id="form4_3" name="55 0 R"  pdfFieldName="55 0 R" onclick="window.location.href='3.html';" style="cursor:pointer;"  title="Page 3" />
<input type="button"  tabindex="4"  id="form4_4" name="52 0 R"  pdfFieldName="52 0 R" onclick="window.location.href='7.html';" style="cursor:pointer;"  title="Page 7" />
<input type="button"  tabindex="8"  id="form4_5" name="56 0 R"  pdfFieldName="56 0 R" onclick="window.location.href='8.html';" style="cursor:pointer;"  title="Page 8" />
<input type="button"  tabindex="1"  id="form4_6" name="49 0 R"  pdfFieldName="49 0 R" onclick="window.location.href='8.html';" style="cursor:pointer;"  title="Page 8" />
<input type="button"  tabindex="3"  id="form4_7" name="51 0 R"  pdfFieldName="51 0 R" onclick="window.location.href='8.html';" style="cursor:pointer;"  title="Page 8" />
<input type="button"  tabindex="5"  id="form4_8" name="53 0 R"  pdfFieldName="53 0 R" onclick="window.location.href='7.html';" style="cursor:pointer;"  title="Page 7" />

</form>
<div id="pg4Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg4"><object width="880" height="1182" data="4/4.svg" type="image/svg+xml" id="pdf4" style="width:880px; height:1182px; background-color:white; -moz-transform:scale(1); z-index: 0;"></object></div>
<!--[if lt IE 9]><script type="text/javascript">
var divCount = 184;
for (var i = 1; i < divCount; i++) {
    var div = document.getElementById("t" + i.toString(36) + "_4");
    if (div !== null) {
        div.style.top = (div.offsetTop * 4) + "px";
        div.style.left = (div.offsetLeft * 4) + "px";
        div.style.zoom = "25%";
    }
}
</script><![endif]-->

</div>
